1103 related articles for article (PubMed ID: 18941402)
21. Mesodermal (müllerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature.
Eichhorn JH; Young RH; Clement PB; Scully RE
Am J Surg Pathol; 2002 Oct; 26(10):1243-58. PubMed ID: 12360039
[TBL] [Abstract][Full Text] [Related]
22. [Uterine adenosarcoma. Apropos of a case of uterine and vaginal adenosarcoma with a corrected genital prolapse].
Kabwa L; Mattei JP; Eloit S; Ramadane A; Grange B
J Chir (Paris); 1997 Jul; 134(2):80-5. PubMed ID: 9378790
[TBL] [Abstract][Full Text] [Related]
23. Adenosarcomas originating from sites other than uterine endometrium.
Inoue M; Fukuda H; Tanizawa O
Int J Gynaecol Obstet; 1995 Mar; 48(3):299-306. PubMed ID: 7781874
[TBL] [Abstract][Full Text] [Related]
24. Uterine Adenosarcoma: a Review.
Nathenson MJ; Ravi V; Fleming N; Wang WL; Conley A
Curr Oncol Rep; 2016 Nov; 18(11):68. PubMed ID: 27718181
[TBL] [Abstract][Full Text] [Related]
25. Müllerian adenosarcoma of the cervix with heterologous elements: report of a case and review of the literature.
Ramos P; Ruiz A; Carabias E; Piñero I; Garzon A; Alvarez I
Gynecol Oncol; 2002 Jan; 84(1):161-6. PubMed ID: 11748995
[TBL] [Abstract][Full Text] [Related]
26. Adenofibroma and adenosarcoma of the uterus: a clinicopathologic study of 35 cases.
Zaloudek CJ; Norris HJ
Cancer; 1981 Jul; 48(2):354-66. PubMed ID: 6263458
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological spectrum of 19 adenosarcomas of female genital tract, including uncommon clinical associations and immunohistochemical profile, reviewed at a single institution.
Rekhi B; Deodhar KK; Maheshwari A; Menon S; Kerkar R; Bajpai J; Ghosh J; Gupta S; Engineer R; Shrivastava SK
Indian J Pathol Microbiol; 2012; 55(3):326-32. PubMed ID: 23032825
[TBL] [Abstract][Full Text] [Related]
28. Endometrial adenofibroma: a rare entity.
Bettaieb I; Mekni A; Bellil K; Haouet S; Bellil S; Kchir N; Chelly H; Zitouna M
Arch Gynecol Obstet; 2007 Mar; 275(3):191-3. PubMed ID: 16858575
[TBL] [Abstract][Full Text] [Related]
29. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
[TBL] [Abstract][Full Text] [Related]
30. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
[TBL] [Abstract][Full Text] [Related]
31. Mullerian adenosarcoma of the cervix in a 10-year-old girl: case report and review of the literature.
Fleming NA; Hopkins L; de Nanassy J; Senterman M; Black AY
J Pediatr Adolesc Gynecol; 2009 Aug; 22(4):e45-51. PubMed ID: 19493521
[TBL] [Abstract][Full Text] [Related]
32. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
33. Management of uterine adenosarcomas with and without sarcomatous overgrowth.
Tanner EJ; Toussaint T; Leitao MM; Hensley ML; Soslow RA; Gardner GJ; Jewell EL
Gynecol Oncol; 2013 Apr; 129(1):140-4. PubMed ID: 23283300
[TBL] [Abstract][Full Text] [Related]
34. Mullerian adenosarcoma of uterine cervix: report of three cases and review of literature.
Manoharan M; Azmi MA; Soosay G; Mould T; Weekes AR
Gynecol Oncol; 2007 Apr; 105(1):256-60. PubMed ID: 17292949
[TBL] [Abstract][Full Text] [Related]
35. Two unusual presentations of müllerian adenosarcoma: case reports, literature review, and treatment considerations.
Gollard R; Kosty M; Bordin G; Wax A; Lacey C
Gynecol Oncol; 1995 Dec; 59(3):412-22. PubMed ID: 8522267
[TBL] [Abstract][Full Text] [Related]
36. CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma.
Van Mieghem T; Abeler VM; Moerman P; Verbist L; Vergote I; Amant F
Gynecol Oncol; 2005 Nov; 99(2):493-6. PubMed ID: 16051333
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
38. The Impact on Survival of an Extensive Sex Cord-like Component in Mullerian Adenosarcomas: A Study Comprising 6 Cases.
Stolnicu S; Molnar C; Barsan I; Boros M; Nogales FF; Soslow RA
Int J Gynecol Pathol; 2016 Mar; 35(2):147-52. PubMed ID: 26535983
[TBL] [Abstract][Full Text] [Related]
39. Endometrioid carcinoma of the fallopian tube: a clinicopathologic analysis of 26 cases.
Navani SS; Alvarado-Cabrero I; Young RH; Scully RE
Gynecol Oncol; 1996 Dec; 63(3):371-8. PubMed ID: 8946874
[TBL] [Abstract][Full Text] [Related]
40. Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature.
Euscher ED; Deavers MT; Lopez-Terrada D; Lazar AJ; Silva EG; Malpica A
Am J Surg Pathol; 2008 Feb; 32(2):219-28. PubMed ID: 18223324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
